AAAAAA

   
Results: 1-8 |
Results: 8
Maternal pyridoxine non-responsive homocystinuria: the role of dietary treatment and anticoagulation
Authors: Yap, S Barry-Kinsella, C Naughten, ER
Citation: S. Yap et al., Maternal pyridoxine non-responsive homocystinuria: the role of dietary treatment and anticoagulation, BR J OBST G, 108(4), 2001, pp. 425-428
Ocular findings among patients with late-diagnosed or poorly controlled homocystinuria compared with a screened, well-controlled population
Authors: Mulvihill, A Yap, S O'Keefe, M Howard, PM Naughten, ER
Citation: A. Mulvihill et al., Ocular findings among patients with late-diagnosed or poorly controlled homocystinuria compared with a screened, well-controlled population, J AAPOS, 5(5), 2001, pp. 311-315
The intellectual abilities of early-treated individuals with pyridoxine-nonresponsive homocystinuria due to cystathionine beta-synthase deficiency
Authors: Yap, S Rushe, H Howard, PM Naughten, ER
Citation: S. Yap et al., The intellectual abilities of early-treated individuals with pyridoxine-nonresponsive homocystinuria due to cystathionine beta-synthase deficiency, J INH MET D, 24(4), 2001, pp. 437-447
Coronary artery bypass surgery on small patients
Authors: Yap, AG Baladi, N Allman, G Avenmarg, J Yap, S Shaw, RE
Citation: Ag. Yap et al., Coronary artery bypass surgery on small patients, J INVAS CAR, 12(5), 2000, pp. 242-246
Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: Effects of homocysteine-lowering therapy
Authors: Yap, S Naughten, ER Wilcken, B Wilcken, DEL Boers, GHJ
Citation: S. Yap et al., Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: Effects of homocysteine-lowering therapy, SEM THROMB, 26(3), 2000, pp. 335-340
The treatment of high homocysteine concentrations in homocystinuria: Biochemical control in patients and their vascular outcome
Authors: Boers, GHJ Yap, S Naughten, E Wilcken, B
Citation: Ghj. Boers et al., The treatment of high homocysteine concentrations in homocystinuria: Biochemical control in patients and their vascular outcome, DEV CARD M, 230, 2000, pp. 389-411
Factor V Leiden (Arg506Gln), a confounding genetic risk factor but not mandatory for the occurrence of venous thromboembolism in homozygotes and obligate heterozygotes for cystathionine beta-synthase deficiency
Authors: Yap, S O'Donnell, KA O'Neill, C Mayne, PD Thornton, P Naughten, E
Citation: S. Yap et al., Factor V Leiden (Arg506Gln), a confounding genetic risk factor but not mandatory for the occurrence of venous thromboembolism in homozygotes and obligate heterozygotes for cystathionine beta-synthase deficiency, THROMB HAEM, 81(4), 1999, pp. 502-505
Characterization of mutations in the cystathionine beta-synthase gene in Irish patients with homocystinuria
Authors: Gallagher, PM Naughten, E Hanson, NQ Schwichtenberg, K Bignell, M Yuan, M Ward, P Yap, S Whitehead, AS Tsai, MY
Citation: Pm. Gallagher et al., Characterization of mutations in the cystathionine beta-synthase gene in Irish patients with homocystinuria, MOL GEN MET, 65(4), 1998, pp. 298-302
Risultati: 1-8 |